| Ad5 | Adenovirus serotype 5 |
| BBB | Blood–brain barrier |
| CNS | Central nervous system |
| CPE | Cytopathic effect |
| CVB3 | Coxsackievirus B3 |
| CVB5 | Coxsackievirus B5 |
| CVB6 | Coxsackievirus B6 |
| CVBs | Group B Coxsackieviruses |
| CXADR | Coxsackievirus and Adenovirus Receptor |
| GB | Glioblastoma |
| H&E | Hematoxylin and eosin |
| ICC | Immunocytochemistry |
| IHC | Immunohistochemistry |
| i.t. | Intratumoral |
| i.v. | Intravenous |
| LEV | Live Enterovirus Vaccine |
| MOI | Multiplicity of infection |
| MRI | Magnetic resonance imaging |
| OVs | Oncolytic viruses |
| TCID50 | 50% tissue culture infectious dose |
| VCO | Vessel co-option |
| VEGF | Vascular endothelial growth factor |
| VSV | Vesicular stomatitis virus |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.